Clinical application: Medical examination center

A large number of studies have shown that hyperlipidemia can cause many diseases, which are closely related to the onset of stroke, myocardial infarction, sudden cardiac death, diabetes, hypertension, fatty liver, etc., it is one of the main factors in the formation of coronary heart disease. In recent years, with the changes in people’s living habits, especially dietary habits, and the influence of various factors, the incidence of hyperlipidemia has increased significantly, and the cardiovascular and cerebrovascular diseases caused by this disease often have a high incidence and are harmful Big and dangerous. Dyslipidemia is one of the important factors leading to atherosclerosis and an independent risk factor for coronary heart disease and ischemic stroke.

 New blood lipids of LEHE：LP-PLA2/RLP-C/sd-LDL

By detecting Lp-PLA2 in the blood, the degree of inflammation and stability of atherosclerotic plaque can be effectively understood. RLP-C lower density lipoprotein (LDL) has a stronger atherogenic effect. sd-LDL can be used as a new indicator to understand lipoprotein metabolism disorders in patients with ACS, and is of great significance for predicting the occurrence of ACS.

Lipid disease

Clinical application

LEHE Products

1. Cardiovascular embolism disease

2. Atherosclerosis

3. Coronary Syndrome

1. Predict the risk of thrombosis

2. Real-time monitoring of the condition

3. Prompt the efficacy of medication

LP-PLA2

RLP-C

sd-LDL